EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 51 filers reported holding EDGE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $753,000 | -60.8% | 2,344,868 | 0.0% | 0.21% | -40.9% |
| Q3 2018 | $1,923,000 | -20.4% | 2,344,868 | 0.0% | 0.35% | -40.0% |
| Q2 2018 | $2,415,000 | -12.7% | 2,344,868 | 0.0% | 0.58% | -61.0% |
| Q1 2018 | $2,767,000 | -87.4% | 2,344,868 | 0.0% | 1.49% | -85.5% |
| Q4 2017 | $21,971,000 | -12.7% | 2,344,868 | 0.0% | 10.28% | -12.0% |
| Q3 2017 | $25,160,000 | +4.6% | 2,344,868 | 0.0% | 11.68% | -30.9% |
| Q2 2017 | $24,058,000 | +12.6% | 2,344,868 | 0.0% | 16.90% | +54.4% |
| Q1 2017 | $21,362,000 | -27.1% | 2,344,868 | 0.0% | 10.94% | -47.9% |
| Q4 2016 | $29,311,000 | +20.1% | 2,344,868 | 0.0% | 20.99% | +19.5% |
| Q3 2016 | $24,410,000 | +3.0% | 2,344,868 | 0.0% | 17.57% | -13.8% |
| Q2 2016 | $23,707,000 | +10.5% | 2,344,868 | 0.0% | 20.40% | +5.0% |
| Q1 2016 | $21,456,000 | -26.8% | 2,344,868 | 0.0% | 19.42% | -1.0% |
| Q4 2015 | $29,311,000 | – | 2,344,868 | – | 19.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,344,868 | $24,058,000 | 16.90% |
| VHCP Management II, LLC | 1,933,582 | $19,839,000 | 7.92% |
| ACUTA CAPITAL PARTNERS, LLC | 1,504,612 | $15,437,000 | 4.32% |
| Opaleye Management Inc. | 130,000 | $1,334,000 | 0.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $1,539,000 | 0.26% |
| DAFNA Capital Management LLC | 19,400 | $199,000 | 0.14% |
| REGENTATLANTIC CAPITAL LLC | 134,900 | $1,384,000 | 0.13% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 14,400 | $148,000 | 0.10% |
| TFS CAPITAL LLC | 20,080 | $206,000 | 0.08% |
| EAGLE ASSET MANAGEMENT INC | 901,359 | $9,247,000 | 0.06% |